Free tool
Diagnostics stocks
We cover 23 companies grouped under the Diagnostics theme. The median market value in the group is $339.65M. Across the group, the median move over the past trading day is +0.48%. 50% of the 22 with a 200-day average trade above it. Price change over the past year runs from −57.6% to +33.7% across the middle 80 percent of the group, with a median of −13.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
23 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0KSX.L | Quest Diagnostics Incorporated | $27.60B | Large cap | +36.94% |
| 0JSY.L | Labcorp Holdings Inc. | $27.37B | Large cap | +20.97% |
| ERF.PA | Eurofins Scientific SE | $14.91B | Large cap | +13.76% |
| ESF0.DE | Eurofins Scientific SE | $14.63B | Large cap | +11.02% |
| BIM.PA | bioMérieux S.A. | $10.40B | Large cap | −37.52% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% |
| CEVI.ST | CellaVision AB (publ) | $413.78M | Small cap | −3.32% |
| VOX.WA | Voxel S.A. | $382.56M | Small cap | −20.15% |
| NIOX.L | NIOX Group Plc | $382.51M | Small cap | −6.05% |
| 0K3W.L | Myriad Genetics, Inc. | $370.48M | Small cap | −46.71% |
| N3B.F | Anbio Biotechnology | $356.84M | Small cap | −86.59% |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $339.65M | Small cap | +80.26% |
| SBS.DE | Stratec SE | $324.34M | Small cap | −16.29% |
| IDHC.L | Integrated Diagnostics Holdings plc | $317.40M | Small cap | +20.85% |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −13.37% |
| ALERS.PA | Eurobio Scientific Société anonyme | $232.78M | Small cap | −18.97% |
| S2B.WA | Syn2bio S.A. | $149.26M | Small cap | +81.79% |
| 0ELV.L | Guerbet SA | $146.82M | Small cap | −62.12% |
| EKF.L | EKF Diagnostics Holdings plc | $144.58M | Small cap | −13.90% |
| BVXP.L | Bioventix PLC | $124.78M | Small cap | −30.64% |
| SCP.WA | Scope Fluidics S.A. | $120.56M | Small cap | −9.34% |
| S84.F | Scope Fluidics S.A. | $119.81M | Small cap | −9.76% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $106.02M | Small cap | −60.27% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.